Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

AI in Food: How Artificial Intelligence is Designing Healthier and More Sustainable Foods

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes. AI-driven tools also support food safety assessment, sustainable food systems, and precision nutrition while raising important governance, equity, and validation challenges.

What does ChatGPT mean for Healthcare?

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

AI Psychosis: How Artificial Intelligence May Trigger Delusions and Paranoia

How Artificial Intelligence Is Revolutionizing Emergency Medicine

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

Applying Deep Learning to Localization Microscopy

Artificial Intelligence in Histopathology

Ethical Considerations in AI-Driven Healthcare

The Medical Industries That Are Most Likely to Be Impacted by Ai

Machine Learning in Drug Development

Deep-Learning in Radiology

See more featured articles »

Uncovering the Mystery of the Human Brain with Computational Neuroscience

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

The Role of AI in Pathogen Detection and Epidemic Prediction

Recent Developments in Health Technology

Is Data at the Center of Healthcare for the Future?

The Pros and Cons of Healthcare Chatbots

Artificial Intelligence in Cardiology

Managing the Explosion of Healthcare Data to Harness its Power

Artificial Intelligence in CBT

Artificial Intelligence and Life Science

Artificial Intelligence and Deep Learning in Medicine

Latest Artificial Intelligence News and Research

Machine learning can help close pregnancy drug safety gaps

JMIR Publications today released a report on developments in the evidence gap in drug safety during pregnancy in its News and Perspectives section.

27 May 2026

Mount Sinai opens integrated clinical center for womens health

The Mount Sinai Health System is opening the Carolyn Rowan Center for Women's Health and Wellness, a transformative new model for women's health that brings together multidisciplinary clinical expertise, structured care pathways, and leading-edge research innovation to deliver more personalized, comprehensive care for women across the entire lifespan.

27 May 2026

Artificial intelligence in mental health settings inherits human bias

A new viewpoint article published in JMIR Mental Health warns that artificial intelligence (AI) systems used in mental health settings may inherit and reinforce unreliable human input unless new safeguards are adopted.

27 May 2026

How the right diet could support the gut bacteria that matter most

This review examines how gut keystone bacteria shape microbiome stability, disease risk, and responses to diet. It highlights why better identification methods, experimental validation, and precision diet-probiotic strategies are needed to restore gut homeostasis.

26 May 2026

New AI tools identify potential drugs for rare Ebola virus

Recent advances in artificial intelligence have enabled Southwest Research Institute (SwRI) to identify nearly two dozen antiviral compounds that could potentially treat a rare species of Ebola virus (Bundibugyo virus) currently affecting the Democratic Republic of Congo.

26 May 2026

New AI model predicts cancer treatment responses from mutations

Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate a tumor's complex genetic profile into predictions about how that cancer may respond to treatment.

26 May 2026

New AI assistant streamlines initial psychiatric consultations for doctors

People often say that seeking psychiatric care can feel intimidating. Patients may feel burdened when they first open up about their emotional distress, while medical staff must accurately understand a patient's extensive history and symptoms within limited consultation time.

26 May 2026

Artificial intelligence models show high accuracy in cardiac care

Cardiac arrest remains one of the most urgent and unforgiving medical emergencies, where every minute can determine survival and neurological recovery.

26 May 2026

Roswell Park scientists present five key cancer studies at clinical meeting

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago.

25 May 2026

How social media, AI, and surveillance can become health determinants

Digital technologies increasingly shape health by mediating how social, political, commercial, and economic conditions affect people’s lives. This Perspective calls for global collaboration to ensure digital transformation promotes health equity rather than reinforcing existing inequities.

24 May 2026

AI-engineered p53 superproteins may reshape future cancer therapies

The Oncodarwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not merely a disease but a potential macro‑immunoadaptive response – a self‑replicating algorithm that can be reprogrammed via AI‑based 3D printed p53 superproteins.

22 May 2026

Lab-grown brain models reveal how epilepsy drug alters fetal development

It is known that the antiepileptic drug valproate increases the risk of developmental disorders in unborn children.

22 May 2026

Explainable AI could make breast cancer drug predictions safer and clearer

AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast cancer treatment. The review proposes an interpretability-driven framework that links multi-omics data, mechanistic validation, and clinical translation to make AI predictions more transparent and clinically useful.

22 May 2026

Study supports routine childhood screening for type 1 diabetes

For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric care.

21 May 2026

Artificial intelligence-based tool could improve multiple myeloma treatment decisions

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.

21 May 2026

New artificial intelligence model maps how genes work together inside cells

Scientists at the Icahn School of Medicine at Mount Sinai have created a new artificial intelligence (AI) model that helps reveal how genes function together inside human cells, offering a powerful new way to understand biology and disease.

21 May 2026

New computational tool uses plain language for genetic diagnosis

A new computational tool called MARRVEL-MCP helps researchers move toward genetic diagnoses more efficiently by analyzing and interpreting vast amounts of genetic and biological information using everyday language.

21 May 2026

Machine learning lifestyle coaching helps reduce major depressive symptoms

More than 21% of U.S. adults experience depression, greatly impacting their quality of life. Many people with mild‑to‑moderate depression can improve their symptoms by adjusting daily habits like sleep, exercise, diet and social interaction, according to Jyoti Mishra, PhD, associate professor of psychiatry at University of California San Diego School of Medicine.

21 May 2026

Key neural circuit helps the brain “change gears”

Most people have experienced the feeling: switching from one task to another, only to find the brain momentarily stuck in the old mode of thinking. Sometimes, even after realizing a strategy no longer works, the mind keeps returning to it anyway.

21 May 2026

AI passed a classic Turing test by mastering the art of human small talk

In a standard three-party Turing test, persona-prompted LLMs were often judged to be human, with GPT-4.5 selected over real people 73% of the time in 5-minute trials. The findings suggest that short human-AI interactions now hinge less on factual intelligence and more on social style, conversational flow, and humanlike persona cues.

20 May 2026